Shim, JoannaJones, Gareth TPathan, Ejaz M IMacfarlane, Gary J2018-11-022018-11-022018-11-01Shim, J, Jones, G T, Pathan, E M I & Macfarlane, G J 2018, 'Impact of biological therapy on work outcomes in patients with axial spondyloarthritis : results from the British Society for Rheumatology Biologics Register (BSRBR-AS) and meta-analysis', Annals of the Rheumatic Diseases, vol. 77, no. 11, pp. 1578-1584. https://doi.org/10.1136/annrheumdis-2018-2135900003-4967ORCID: /0000-0003-2322-3314/work/72631747ORCID: /0000-0003-0016-7591/work/83704081http://hdl.handle.net/2164/11385Funding The BSRBR-AS is funded by the British Society for Rheumatology who have received funding for this from Pfizer, AbbVie and UCB. These companies receive advance copies of manuscripts for comments. This work was conducted within the Arthritis Research UK/Medical Research Council Centre for Musculoskeletal Work and Health (Grant No: 20665) Acknowledgements We are grateful to the staff of the British Society for Rheumatology Biologics Register in Axial Spondyloarthritis register who are currently Claudia Zabke, Maureen Heddle, Nafeesa Nazlee and Barry Morris, and to the recruiting staff at the clinical centres, details of which are available at: https://www.abdn.ac.uk/iahs/research/epidemiology/spondyloarthritis.php#panel1011. We would like to thank Dr Atul Deodhar, Benjamin Hsu and Chenglong Han for providing additional data relating to one of the studies, to allow it be included in the meta-analysis.7883975engR MedicineArthritis Research UK (ARUK)20665Medical Research Council (MRC)20665RJournal article10.1136/annrheumdis-2018-2135907711